Cargando…

Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients

BACKGROUND: Shock and organ damage occur in critically ill patients in the emergency department because of biological responses to invasion, and cytokines play an important role in their development. It is important to predict early multiple organ dysfunction (MOD) because it is useful in predicting...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Shigeto, Teshima, Yuto, Otsubo, Hiroki, Shimazui, Takashi, Nakada, Taka-aki, Takasu, Osamu, Matsuda, Kenichi, Sasaki, Junichi, Nabeta, Masakazu, Moriguchi, Takeshi, Shibusawa, Takayuki, Mayumi, Toshihiko, Oda, Shigeto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573766/
https://www.ncbi.nlm.nih.gov/pubmed/34749673
http://dx.doi.org/10.1186/s12873-021-00534-z
_version_ 1784595490011086848
author Ishikawa, Shigeto
Teshima, Yuto
Otsubo, Hiroki
Shimazui, Takashi
Nakada, Taka-aki
Takasu, Osamu
Matsuda, Kenichi
Sasaki, Junichi
Nabeta, Masakazu
Moriguchi, Takeshi
Shibusawa, Takayuki
Mayumi, Toshihiko
Oda, Shigeto
author_facet Ishikawa, Shigeto
Teshima, Yuto
Otsubo, Hiroki
Shimazui, Takashi
Nakada, Taka-aki
Takasu, Osamu
Matsuda, Kenichi
Sasaki, Junichi
Nabeta, Masakazu
Moriguchi, Takeshi
Shibusawa, Takayuki
Mayumi, Toshihiko
Oda, Shigeto
author_sort Ishikawa, Shigeto
collection PubMed
description BACKGROUND: Shock and organ damage occur in critically ill patients in the emergency department because of biological responses to invasion, and cytokines play an important role in their development. It is important to predict early multiple organ dysfunction (MOD) because it is useful in predicting patient outcomes and selecting treatment strategies. This study examined the accuracy of biomarkers, including interleukin (IL)-6, in predicting early MOD in critically ill patients compared with that of quick sequential organ failure assessment (qSOFA). METHODS: This was a multicenter observational sub-study. Five universities from 2016 to 2018. Data of adult patients with systemic inflammatory response syndrome who presented to the emergency department or were admitted to the intensive care unit were prospectively evaluated. qSOFA score and each biomarker (IL-6, IL-8, IL-10, tumor necrosis factor-α, C-reactive protein, and procalcitonin [PCT]) level were assessed on Days 0, 1, and 2. The primary outcome was set as MOD on Day 2, and the area under the curve (AUC) was analyzed to evaluate qSOFA scores and biomarker levels. RESULTS: Of 199 patients, 38 were excluded and 161 were included. Patients with MOD on Day 2 had significantly higher qSOFA, SOFA, and Acute Physiology and Chronic Health Evaluation II scores and a trend toward worse prognosis, including mortality. The AUC for qSOFA score (Day 0) that predicted MOD (Day 2) was 0.728 (95% confidence interval [CI]: 0.651–0.794). IL-6 (Day 1) showed the highest AUC among all biomarkers (0.790 [95% CI: 0.711–852]). The combination of qSOFA (Day 0) and IL-6 (Day 1) showed improved prediction accuracy (0.842 [95% CI: 0.771–0.893]). The combination model using qSOFA (Day 1) and IL-6 (Day 1) also showed a higher AUC (0.868 [95% CI: 0.799–0.915]). The combination model of IL-8 and PCT also showed a significant improvement in AUC. CONCLUSIONS: The addition of IL-6, IL-8 and PCT to qSOFA scores improved the accuracy of early MOD prediction. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12873-021-00534-z.
format Online
Article
Text
id pubmed-8573766
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85737662021-11-08 Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients Ishikawa, Shigeto Teshima, Yuto Otsubo, Hiroki Shimazui, Takashi Nakada, Taka-aki Takasu, Osamu Matsuda, Kenichi Sasaki, Junichi Nabeta, Masakazu Moriguchi, Takeshi Shibusawa, Takayuki Mayumi, Toshihiko Oda, Shigeto BMC Emerg Med Research BACKGROUND: Shock and organ damage occur in critically ill patients in the emergency department because of biological responses to invasion, and cytokines play an important role in their development. It is important to predict early multiple organ dysfunction (MOD) because it is useful in predicting patient outcomes and selecting treatment strategies. This study examined the accuracy of biomarkers, including interleukin (IL)-6, in predicting early MOD in critically ill patients compared with that of quick sequential organ failure assessment (qSOFA). METHODS: This was a multicenter observational sub-study. Five universities from 2016 to 2018. Data of adult patients with systemic inflammatory response syndrome who presented to the emergency department or were admitted to the intensive care unit were prospectively evaluated. qSOFA score and each biomarker (IL-6, IL-8, IL-10, tumor necrosis factor-α, C-reactive protein, and procalcitonin [PCT]) level were assessed on Days 0, 1, and 2. The primary outcome was set as MOD on Day 2, and the area under the curve (AUC) was analyzed to evaluate qSOFA scores and biomarker levels. RESULTS: Of 199 patients, 38 were excluded and 161 were included. Patients with MOD on Day 2 had significantly higher qSOFA, SOFA, and Acute Physiology and Chronic Health Evaluation II scores and a trend toward worse prognosis, including mortality. The AUC for qSOFA score (Day 0) that predicted MOD (Day 2) was 0.728 (95% confidence interval [CI]: 0.651–0.794). IL-6 (Day 1) showed the highest AUC among all biomarkers (0.790 [95% CI: 0.711–852]). The combination of qSOFA (Day 0) and IL-6 (Day 1) showed improved prediction accuracy (0.842 [95% CI: 0.771–0.893]). The combination model using qSOFA (Day 1) and IL-6 (Day 1) also showed a higher AUC (0.868 [95% CI: 0.799–0.915]). The combination model of IL-8 and PCT also showed a significant improvement in AUC. CONCLUSIONS: The addition of IL-6, IL-8 and PCT to qSOFA scores improved the accuracy of early MOD prediction. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12873-021-00534-z. BioMed Central 2021-11-08 /pmc/articles/PMC8573766/ /pubmed/34749673 http://dx.doi.org/10.1186/s12873-021-00534-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ishikawa, Shigeto
Teshima, Yuto
Otsubo, Hiroki
Shimazui, Takashi
Nakada, Taka-aki
Takasu, Osamu
Matsuda, Kenichi
Sasaki, Junichi
Nabeta, Masakazu
Moriguchi, Takeshi
Shibusawa, Takayuki
Mayumi, Toshihiko
Oda, Shigeto
Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients
title Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients
title_full Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients
title_fullStr Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients
title_full_unstemmed Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients
title_short Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients
title_sort risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573766/
https://www.ncbi.nlm.nih.gov/pubmed/34749673
http://dx.doi.org/10.1186/s12873-021-00534-z
work_keys_str_mv AT ishikawashigeto riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT teshimayuto riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT otsubohiroki riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT shimazuitakashi riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT nakadatakaaki riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT takasuosamu riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT matsudakenichi riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT sasakijunichi riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT nabetamasakazu riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT moriguchitakeshi riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT shibusawatakayuki riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT mayumitoshihiko riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT odashigeto riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients